Literature DB >> 7114301

Comparative study of platelet dense granule constituents.

K M Meyers, H Holmsen, C L Seachord.   

Abstract

Cat, cattle, dog, horse, human, mink, pig, and rabbit platelets were separated from plasma by gel filtration. The gel-filtered platelets (GFP) were treated with thrombin to induce maximal granule secretion and the potential dense granule constituents ATP, ADP, serotonin (5-HT), Ca2+, and Mg2+ were measured in GFP and in the control and thrombin-treated platelets and in the respective supernatants. The amount of Ca2+, Mg2+, 5-HT, ATP, and ADP within the nonreleasable pool for all species varied between 3.1 and 10.0 mumol/10(11) platelets for Ca2+ and Mg2+ was less than 1.5 mumol/10(11) platelets for ADP and 5-HT and was between 2.0 and 5.0 mumol/10(11) platelets for ATP. Marked differences were observed in the releasable fraction. Human platelets were characterized by the largest releasable Ca2+ pool (greater than 10 mumol/10(11) platelets), the smallest secretable 5-HT and Mg2+ pool (less than 0.5 mumol/10(11) platelets), and the lowest ATP-to-ADP ratio (greater than 1.0). Pig platelets had the highest amount of releasable Mg2+ (approximately 8.0 mumol/10(11) platelets). Rabbits platelets released the most 5-HT (greater than 3.0 mumol/10(11)) and had the highest ATP/ADP (greater than 5.0). The releasable pool of Ca2+, Mg2+, ATP, and ADP in the remaining species varied in mumol/10(11) platelets from approximately 1.5-4.0, approximately 1.0-3.0, 0.5-3.5, and approximately 0.5-1.5, respectively.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7114301     DOI: 10.1152/ajpregu.1982.243.3.R454

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  25 in total

1.  Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.

Authors:  D M Vanags; S E Rodgers; E M Duncan; J V Lloyd; F Bochner
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

2.  Quantal regulation and exocytosis of platelet dense-body granules.

Authors:  Shencheng Ge; Emily Woo; Christy L Haynes
Journal:  Biophys J       Date:  2011-11-15       Impact factor: 4.033

3.  Enhancement of thrombogenesis by plasma fibronectin cross-linked to fibrin and assembled in platelet thrombi.

Authors:  Jaehyung Cho; Deane F Mosher
Journal:  Blood       Date:  2006-01-03       Impact factor: 22.113

4.  Determination of ATP and ADP Secretion from Human and Mouse Platelets by an HPLC Assay.

Authors:  Michael von Papen; Stepan Gambaryan; Claudia Schütz; Jörg Geiger
Journal:  Transfus Med Hemother       Date:  2013-03-15       Impact factor: 3.747

5.  Significant differences in single-platelet biophysics exist across species but attenuate during clot formation.

Authors:  Oluwamayokun Oshinowo; Renee Copeland; Yumiko Sakurai; Meredith E Fay; Brian G Petrich; Traci Leong; Benjamin Brainard; Wilbur A Lam
Journal:  Blood Adv       Date:  2021-01-26

6.  Impact of fibronectin assembly on platelet thrombus formation in response to type I collagen and von Willebrand factor.

Authors:  Jaehyung Cho; Deane F Mosher
Journal:  Blood       Date:  2006-05-30       Impact factor: 22.113

7.  Activated platelets contribute to stimulation of cardiac afferents during ischaemia in cats: role of 5-HT(3) receptors.

Authors:  Liang-Wu Fu; John C Longhurst
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

8.  Myocardial ischemia-mediated excitatory reflexes: a new function for thromboxane A2?

Authors:  Liang-Wu Fu; Andrew Phan; John C Longhurst
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-24       Impact factor: 4.733

Review 9.  Platelet function and Isoprostane biology. Should isoprostanes be the newest member of the orphan-ligand family?

Authors:  Harold J Ting; Fadi T Khasawneh
Journal:  J Biomed Sci       Date:  2010-04-06       Impact factor: 8.410

10.  Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS).

Authors:  J G Milton; M M Frojmovic; S S Tang; J G White
Journal:  Am J Pathol       Date:  1984-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.